Brian Laffin
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
Papers in
-
- Epigenetics and DNA Methylation 2
- Oncology 5
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- J. Mark Petrash (3 shared papers)Richard P. Metz (5 shared papers)Weston W. Porter (5 shared papers)Dean G. Tang (3 shared papers)Xin Liu (2 shared papers)Jichao Qin (2 shared papers)Hangwen Li (2 shared papers)Xin Chen (2 shared papers)
- Journals
- Molecular and Cellular Biology (1 paper)Journal of Biological Chemistry (1 paper)Oncotarget (1 paper)Toxicology (1 paper)Cell stem cell (1 paper)
- Partner nations
- United StatesChinaHungary
In The Last Decade
Brian Laffin
14 papers receiving 849 citations
Peers
Comparison fields: 5 of 86
- Oncology 345
- Cancer Research 177
- Pulmonary and Respiratory Medicine 228
- Endocrine and Autonomic Systems 46
- Cell Biology 110
Countries citing papers authored by Brian Laffin
This map shows the geographic impact of Brian Laffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Laffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Laffin more than expected).
Fields of papers citing papers by Brian Laffin
This network shows the impact of papers produced by Brian Laffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Laffin. The network helps show where Brian Laffin may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Laffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 243 | |
| 2 | 2013 | 88 | |
| 3 | 2012 | 83 | |
| 4 | 2007 | 70 | |
| 5 | 2018 | 69 | |
| 6 | 2015 | 58 | |
| 7 | 2009 | 50 | |
| 8 | 2005 | 49 | |
| 9 | 2006 | 46 | |
| 10 | 2012 | 45 | |
| 11 | 2006 | 27 | |
| 12 | 2009 | 25 | |
| 13 | 2024 | 5 | |
| 14 | Beta-glucogallin Suppresses Lipopolysaccharide-induced Inflammatory Markers by Aldose Reductase Inhibition in Murine Macrophages and Ocular Tissues | 2013 | 1 |
About Brian Laffin
Brian Laffin is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 14 papers that have together received 859 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Aldose Reductase and Taurine (3 papers), Epigenetics and DNA Methylation (2 papers), Ginger and Zingiberaceae research (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer-related Molecular Pathways (2 papers), Immunotherapy and Immune Responses (2 papers) and Prenatal Substance Exposure Effects (1 paper). The work is most often cited by research in Oncology (345 citations), Cancer Research (177 citations), Pulmonary and Respiratory Medicine (228 citations), Endocrine and Autonomic Systems (46 citations) and Cell Biology (110 citations). Brian Laffin has collaborated with scholars based in United States, China and Hungary. Frequent co-authors include J. Mark Petrash, Richard P. Metz, Weston W. Porter, Dean G. Tang, Xin Liu, Jichao Qin, Hangwen Li, Xin Chen, Collene Jeter and Jiaoti Huang. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Oncotarget, Toxicology and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.